MedTrace Logo

Pre-Emptive Analgesia Efficacy of Etoricoxib for Postoperative Pain

NCT00149253 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2005-09-08

No results posted yet for this study

Summary

Taken together, studies of the value of pre-emptive analgesia are inconclusive. This randomized, double-blind, dose-ranging, placebo-controlled study was therefore designed to test that a reduction in post-operative morphine consumption can be achieved by a single-dose of etoricoxib before induction of anesthesia.

Conditions

  • a Single-Dose of Etoricoxib
  • Post-Operative Morphine Consumption
  • Total Pain Relief Over 8 Hr(TOPAR8)
  • Post Transabdominal Hysterectomy

Interventions

DRUG

a single-dose of Etoricoxib before induction of anesthesia

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • waraporn chau-in, Asso Prof. · Department of Anesthesiology, Faculty of Medicine,KhonKaen University,KhonKaen 40002, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-12-31
Completion
2005-05-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149253 on ClinicalTrials.gov